Blood Pressure in Patients With Migraine Treated With Monoclonal Anti-CGRP (Receptor) Antibodies: A Prospective Follow-up Study.
Simone de Vries LentschBritt W H van der ArendAntoinette MaassenVanDenBrinkGisela M TerwindtPublished in: Neurology (2022)
This study provides Class III evidence that anti-CGRP (receptor) antibodies increase BP when used to treat patients with migraine.